PKC activates BKCa channels in rat pulmonary arterial smooth muscle via cGMP-dependent protein kinase

Scott A Barman1, Shu Zhu, Richard E White

  • 1Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta, GA 30912, USA. sbarman@mail.mcg.edu

Insights

Protein kinase C (PKC) activation in rat pulmonary arteries increases large-conductance, calcium- and voltage-activated potassium (BK(Ca)) channel activity. This pathway, mediated by cyclic GMP-dependent protein kinase, promotes pulmonary vasodilatation.

Area of Science:

  • Physiology
  • Molecular Biology
  • Pharmacology

Background:

  • Large-conductance, calcium- and voltage-activated potassium (BK(Ca)) channels regulate pulmonary vascular tone.
  • Inhibition of BK(Ca) channels is linked to pulmonary vasoconstriction.
  • Protein kinase C (PKC) is known to cause pulmonary vasoconstriction, but its effect on BK(Ca) channels in pulmonary vasculature is unclear.

Purpose of the Study:

  • To investigate the effect of PKC on BK(Ca)-channel activity in pulmonary arterial smooth muscle cells (PASMCs).
  • To elucidate the signaling pathway involved in PKC-mediated BK(Ca)-channel modulation in pulmonary vasculature.

Main Methods:

  • Patch-clamp electrophysiology was used to study BK(Ca)-channel activity in rat PASMCs.
  • PKC activators (phorbol myristate acetate, thymeleatoxin) and inhibitors (Gö-6983, rottlerin) were employed.
  • Specific protein kinase antagonists (KT-5823 for cGMP-dependent kinase, KT-5720 for cAMP-dependent kinase) were used.
  • Vasodilatation was assessed in isolated pulmonary arterial vessels.

Main Results:

  • PKC activators (PMA, thymeleatoxin) increased BK(Ca)-channel activity in PASMCs.
  • The effects of PMA and thymeleatoxin were blocked by PKC inhibitors (Gö-6983, rottlerin).
  • The response to PKC activation was inhibited by a cGMP-dependent protein kinase antagonist (KT-5823) but not by a cAMP-dependent protein kinase antagonist (KT-5720).
  • In isolated vessels, PMA and forskolin induced vasodilatation, which was attenuated by KT-5823, Gö-6983, or a BK(Ca)-channel blocker (tetraethylammonium).

Conclusions:

  • Specific PKC isozymes activate BK(Ca) channels in rat PASMCs.
  • This activation occurs via a pathway involving cyclic GMP-dependent protein kinase.
  • This represents a novel signaling mechanism contributing to pulmonary vasodilatation.

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...